Mild Prolongation of Prothrombin Time Does Not Affect the Safety and Prognosis of Transjugular Intrahepatic Portal Shunt: Based on Real-World Data

Mild Prolongation of Prothrombin Time Does Not Affect the Safety and Prognosis of Transjugular Intrahepatic Portal Shunt: Based on Real-World Data

Bibliographic Details
Main Authors:	Yaowei Bai, Jiacheng Liu, Yang Chen, Chongtu Yang, Yingliang Wang, Chaoyang Wang, Shuguang Ju, Chen Zhou, Songjiang Huang, Tongqiang Li, Wei Yao, Jinghong Yao, Bin Xiong
Format:	Article
Language:	English
Published:	AVES 2023-08-01
Series:	The Turkish Journal of Gastroenterology
Online Access:	https://www.turkjgastroenterol.org/en/mild-prolongation-of-prothrombin-time-does-not-affect-the-safety-and-prognosis-of-transjugular-intrahepatic-portal-shunt-based-on-real-world-data-137095

Similar Items

The impact of thrombocytopenia on variceal bleeding in cirrhotic patients with transjugular intrahepatic portosystemic shunt
by: Yang Chen, et al.
Published: (2023-01-01)

Dynamic changes in liver function after transjugular intrahepatic portosystemic shunt in patients with cirrhosis
by: Chaoyang Wang, et al.
Published: (2022-11-01)

Comparison of specialized stent versus generic stent and bare stent combination for transjugular intrahepatic portosystemic shunt creation
by: Yaowei Bai, et al.
Published: (2024-06-01)

Transjugular intrahepatic portosystemic shunt for the treatment of hepatic sinusoidal obstruction syndrome caused by pyrrolizidine alkaloids: A multicenter retrospective study
by: Chaoyang Wang, et al.
Published: (2024-01-01)

Portal flow diversion based on portography is superior than puncture site in the prediction of overt hepatic encephalopathy after TIPS creation
by: Chongtu Yang, et al.
Published: (2022-07-01)

Transjugular Intrahepatic Portosystemic Shunt Versus Surgical Shunting in the Management of Portal Hypertension
by: Long Huang, et al.
Published: (2015-01-01)

Transjugular Intrahepatic Portosystemic Shunt for the Treatment of Portal Hypertension in Noncirrhotic Patients with Portal Cavernoma
by: Xuefeng Luo, et al.
Published: (2014-01-01)

A comprehensive review of prognostic scoring systems to predict survival after transjugular intrahepatic portosystemic shunt placement
by: Chongtu Yang, et al.
Published: (2022-09-01)

Psoas muscle index in sarcopenia following transjugular intrahepatic portosystemic shunt: A multicenter, retrospective study
by: Tongqiang Li, et al.
Published: (2024-12-01)

The Transjugular Intrahepatic Portosystemic Shunt in the Treatment of Portal Hypertension: Current Status
by: Gilles Pomier-Layrargues, et al.
Published: (2012-01-01)

Transjugular intrahepatic portal shunt in the treatment of portal hypertension due to cirrhosis: single center experience
by: Yun Chen, et al.
Published: (2019-12-01)

Safety and efficacy of transjugular intrahepatic portosystemic shunt therapy for symptomatic portal biliopathy
by: Feng Zhang, et al.
Published: (2023-09-01)

Apatinib Plus Camrelizumab With/Without Chemoembolization for Hepatocellular Carcinoma: A Real-World Experience of a Single Center
by: Shuguang Ju, et al.
Published: (2022-01-01)

Shunt dysfunction and mortality after transjugular intrahepatic portosystemic shunt (TIPS) in patients with portal hypertension
by: Laura Büttner, et al.
Published: (2024-08-01)

Microwave ablation combined with anti-PD-1 therapy enhances systemic antitumor immunity in a multitumor murine model of Hepa1-6
by: Songjiang Huang, et al.
Published: (2022-12-01)

Advanced portal venous access techniques for transjugular intrahepatic portosystemic shunt placement
by: Xin Li, et al.
Published: (2021-10-01)

Techniques for portal vein targeting during a transjugular intrahepatic portosystemic shunt
by: Dan Laney, et al.
Published: (2024-01-01)

Transjugular intrahepatic portosystemic shunt for portal hypertension in a patient with Caroli disease
by: Baoli Qi, et al.
Published: (2023-07-01)

The role of transjugular intrahepatic portosystemic shunt in patients with portal hypertension: Advantages and pitfalls
by: Hae Lim Lee, et al.
Published: (2022-04-01)

Retrospective Study of Transjugular Intrahepatic Portosystemic Shunt Placement for Cirrhotic Portal Hypertension
by: Sara Santos, et al.
Published: (2020-06-01)

A new choice of stent for transjugular intrahepatic portosystemic shunt creation: Viabahn ePTFE covered stent/bare metal stent combination
by: Jiacheng Liu, et al.
Published: (2021-02-01)

Use of transabdominal ultrasound-guided transjugular portal vein puncture on radiation dose in transjugular intrahepatic portosystemic shunt formation
by: Aniket N. Tavare, et al.
Published: (2017-05-01)

Transjugular Intrahepatic Portosystemic Shunt as the Treatment for Refractory Hepatic Hydrothorax with Portal Vein Thrombosis
by: Lin-Hao Zhang, et al.
Published: (2017-01-01)

The time window for pre-emptive transjugular intrahepatic portosystemic shunt could be extended to 5 days
by: Xiangjun Dong, et al.
Published: (2024-02-01)

Adverse events after the transjugular intrahepatic portal shunt are linked to serum metabolomic changes following the procedure
by: Quan Chen, et al.
Published: (2023-05-01)

Retrospective study of hepatic encephalopathy by different transjugular intrahepatic portosystemic shunt ways in portal hypertension
by: Xin Huo, et al.
Published: (2019-01-01)

Transjugular intrahepatic portosystemic shunt for repeated bleeding of hemorrhoids caused by severe portal hypertension with ectopic varices: A case report
by: Qin Shi, et al.
Published: (2020-09-01)

Transsplenic portal vein reconstruction–transjugular intrahepatic portosystemic shunt in a patient with portal and splenic vein thrombosis
by: Jason T. Salsamendi, MD, et al.
Published: (2016-09-01)

Comparison of Transjugular Intrahepatic Portosystemic Shunt in the Treatment of Cirrhosis With or Without Portal Vein Thrombosis: A Retrospective Study
by: Hong-Liang Wang, et al.
Published: (2021-10-01)

The Role of Transjugular Intrahepatic Portosystemic Shunt (TIPS) in Treating Portal Hypertension in Patients with Hepatocellular Carcinoma
by: Daniele Balducci, et al.
Published: (2023-06-01)

Status of transjugular intrahepatic portosystemic shunt for portal hypertension in China: A national survey analysis
by: Haibo Shao, et al.
Published: (2023-03-01)

Natural History and Influence on Long-term Outcomes of Isolated Type II Endoleak after Endovascular Aneurysm Repair: A 10-year Experience at a Single Center
by: Yingliang Wang, et al.
Published: (2022-03-01)

Late combination of transarterial chemoembolization with apatinib and camrelizumab for unresectable hepatocellular carcinoma is superior to early combination
by: Shuguang Ju, et al.
Published: (2022-03-01)

Sonographic evaluation of transjugular intrahepatic porto-systemic shunt
by: A Van Holsbeeck, et al.
Published: (2013-09-01)

Transjugular intrahepatic portosystemic shunt assisted with trans-splenic access
by: Zhang Cheng, et al.
Published: (2019-12-01)

Sleep disturbance in patients with cirrhosis and transjugular intrahepatic portosystemic shunt
by: Zhao, M, et al.
Published: (2024)

Sleep disturbance in patients with cirrhosis and transjugular intrahepatic portosystemic shunt
by: Ming Zhao, et al.
Published: (2024-10-01)

Application of percutaneous transluminal sharp recanalization in transjugular intrahepatic portosystemic shunt for patients with chronic portal vein occlusion
by: Mingan Li, et al.
Published: (2021-03-01)

The Pull-Through Technique for Recanalization of Transjugular Intrahepatic Portosystemic Shunt Dysfunction
by: Si-liang Chen, et al.
Published: (2020-01-01)

Are TIPS Tops in the Treatment of Portal Hypertension? A Review on the Use and Misuse of Transjugular Intrahepatic Portosystemic Shunts
by: Richard K Sterling, et al.
Published: (2000-01-01)